Trademark: 87531199
Word
CASEBIA THERAPEUTICS
Status Date
Tuesday, January 18, 2022
Filing Date
Monday, July 17, 2017
Published for Opposition
Tuesday, November 23, 2021
5 Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
42 Research and development of human therapeutics using gene editing; pharmaceutical research and development services
The mark consists of of the words "CASEBIA" above "THERAPEUTICS", to the left of which are the images of a circle, square and pentagon, presented in an overlapping vertical arrangement.
Color is not claimed as a feature of the mark.
"THERAPEUTICS"
Jan 18, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 23, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2021
Published For Opposition
Nov 3, 2021
Notification Of Notice Of Publication E-Mailed
Oct 21, 2021
Approved For Pub - Principal Register
Apr 21, 2021
Report Completed Suspension Check Case Still Suspended
Oct 21, 2020
Report Completed Suspension Check Case Still Suspended
Apr 21, 2020
Report Completed Suspension Check Case Still Suspended
Oct 21, 2019
Report Completed Suspension Check Case Still Suspended
Apr 19, 2019
Report Completed Suspension Check Case Still Suspended
Oct 19, 2018
Report Completed Suspension Check Case Still Suspended
Apr 12, 2018
Notification Of Letter Of Suspension E-Mailed
Apr 12, 2018
Letter Of Suspension E-Mailed
Apr 12, 2018
Suspension Letter Written
Apr 12, 2018
Examiner's Amendment Entered
Apr 12, 2018
Notification Of Examiners Amendment E-Mailed
Apr 12, 2018
Examiners Amendment E-Mailed
Apr 12, 2018
Examiners Amendment -Written
Apr 9, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 9, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 24, 2017
Notification Of Non-Final Action E-Mailed
Oct 24, 2017
Non-Final Action E-Mailed
Oct 24, 2017
Non-Final Action Written
Oct 16, 2017
Assigned To Examiner
Jul 25, 2017
Notice Of Design Search Code E-Mailed
Jul 24, 2017
New Application Office Supplied Data Entered In Tram
Jul 20, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
